Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Remodeling of Chlamydomonas metabolism using synthetic inducers results in lipid storage during growth.

Wase N, Tu B, Rasineni GK, Cerny R, Grove R, Adamec J, Black PN, DiRusso CC.

Plant Physiol. 2019 Sep 9. pii: pp.00758.2019. doi: 10.1104/pp.19.00758. [Epub ahead of print]

2.

Experimental studies on zeta potential of flocculants for harvesting of algae.

Pandey A, Pathak VV, Kothari R, Black PN, Tyagi VV.

J Environ Manage. 2019 Feb 1;231:562-569. doi: 10.1016/j.jenvman.2018.09.096. Epub 2018 Oct 30.

PMID:
30388653
3.

Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival.

Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, DiRusso CC, Cook L, Talmadge JE.

Clin Exp Metastasis. 2018 Dec;35(8):797-818. doi: 10.1007/s10585-018-9941-7. Epub 2018 Oct 16.

PMID:
30327985
4.

Induction of oil accumulation by heat stress is metabolically distinct from N stress in the green microalgae Coccomyxa subellipsoidea C169.

Allen JW, Tevatia R, Demirel Y, DiRusso CC, Black PN.

PLoS One. 2018 Sep 27;13(9):e0204505. doi: 10.1371/journal.pone.0204505. eCollection 2018.

5.

Long-Chain Omega-3 Polyunsaturated Fatty Acids Modulate Mammary Gland Composition and Inflammation.

Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, DiRusso CC, Talmadge JE.

J Mammary Gland Biol Neoplasia. 2018 Jun;23(1-2):43-58. doi: 10.1007/s10911-018-9391-5. Epub 2018 Mar 25.

PMID:
29574638
6.

Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology.

Khadge S, Sharp JG, Thiele GM, McGuire TR, Klassen LW, Duryee MJ, Britton HC, Dafferner AJ, Beck J, Black PN, DiRusso CC, Talmadge J.

J Nutr Biochem. 2018 Feb;52:92-102. doi: 10.1016/j.jnutbio.2017.09.017. Epub 2017 Oct 4.

7.

Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae.

Wase N, Tu B, Allen JW, Black PN, DiRusso CC.

Plant Physiol. 2017 Aug;174(4):2146-2165. doi: 10.1104/pp.17.00433. Epub 2017 Jun 26. Erratum in: Plant Physiol. 2017 Oct;175(2):995.

8.

Electronic adherence monitoring device performance and patient acceptability: a randomized control trial.

Chan AHY, Stewart AW, Harrison J, Black PN, Mitchell EA, Foster JM.

Expert Rev Med Devices. 2017 May;14(5):401-411. doi: 10.1080/17434440.2017.1322505. Epub 2017 May 3.

PMID:
28434269
9.

Carbon and Acyl Chain Flux during Stress-induced Triglyceride Accumulation by Stable Isotopic Labeling of the Polar Microalga Coccomyxa subellipsoidea C169.

Allen JW, DiRusso CC, Black PN.

J Biol Chem. 2017 Jan 6;292(1):361-374. doi: 10.1074/jbc.M116.760843. Epub 2016 Nov 30.

10.

Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.

Black PN, Ahowesso C, Montefusco D, Saini N, DiRusso CC.

Medchemcomm. 2016 Apr 1;7(4):612-622. Epub 2016 Feb 19.

11.

Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death.

Ahowesso C, Black PN, Saini N, Montefusco D, Chekal J, Malosh C, Lindsley CW, Stauffer SR, DiRusso CC.

Biochem Pharmacol. 2015 Nov 1;98(1):167-81. doi: 10.1016/j.bcp.2015.09.004. Epub 2015 Sep 21.

12.
13.

Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity.

Saini N, Black PN, Montefusco D, DiRusso CC.

Biochem Biophys Res Commun. 2015 Sep 25;465(3):534-41. doi: 10.1016/j.bbrc.2015.08.055. Epub 2015 Aug 15.

14.

Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians.

Chan AH, Harrison J, Black PN, Mitchell EA, Foster JM.

J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):335-49.e1-5. doi: 10.1016/j.jaip.2015.01.024. Epub 2015 Apr 1. Review.

PMID:
25840665
15.

The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial.

Chan AH, Stewart AW, Harrison J, Camargo CA Jr, Black PN, Mitchell EA.

Lancet Respir Med. 2015 Mar;3(3):210-9. doi: 10.1016/S2213-2600(15)00008-9. Epub 2015 Jan 21.

PMID:
25617215
16.

Integrated quantitative analysis of nitrogen stress response in Chlamydomonas reinhardtii using metabolite and protein profiling.

Wase N, Black PN, Stanley BA, DiRusso CC.

J Proteome Res. 2014 Mar 7;13(3):1373-96. doi: 10.1021/pr400952z. Epub 2014 Feb 26.

PMID:
24528286
17.

WITHDRAWN: Prophylactic antibiotic therapy for chronic bronchitis.

Staykova T, Black PN, Chacko EE, Poole P.

Cochrane Database Syst Rev. 2013 Nov 29;(11):CD004105. doi: 10.1002/14651858.CD004105.pub2. Review. No abstract available.

PMID:
24293291
18.

Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids.

Melton EM, Cerny RL, DiRusso CC, Black PN.

Biochem Biophys Res Commun. 2013 Nov 1;440(4):743-8. doi: 10.1016/j.bbrc.2013.09.137. Epub 2013 Oct 8.

19.

Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?

Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, Siebers R, Black PN, Crane J.

Clin Exp Allergy. 2013 Sep;43(9):1048-57. doi: 10.1111/cea.12154.

PMID:
23957340
20.

Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Burgers JS, Anzueto A, Black PN, Cruz AA, Fervers B, Graham ID, Metersky M, Woodhead M, Yawn BP; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):304-10. doi: 10.1513/pats.201208-067ST. Review.

PMID:
23256175
21.

Coherent anti-Stokes Raman scattering and spontaneous Raman spectroscopy and microscopy of microalgae with nitrogen depletion.

He XN, Allen J, Black PN, Baldacchini T, Huang X, Huang H, Jiang L, Lu YF.

Biomed Opt Express. 2012 Nov 1;3(11):2896-906. doi: 10.1364/BOE.3.002896. Epub 2012 Oct 18.

22.

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.

Poole P, Black PN, Cates CJ.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD001287. doi: 10.1002/14651858.CD001287.pub4. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD001287.

PMID:
22895919
23.

Surface-enhanced Raman spectroscopy using gold-coated horizontally aligned carbon nanotubes.

He XN, Gao Y, Mahjouri-Samani M, Black PN, Allen J, Mitchell M, Xiong W, Zhou YS, Jiang L, Lu YF.

Nanotechnology. 2012 May 25;23(20):205702. doi: 10.1088/0957-4484/23/20/205702. Epub 2012 Apr 30.

PMID:
22543450
24.

Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung.

Zhang J, Wu L, Qu JM, Bai CX, Merrilees MJ, Black PN.

J Cell Mol Med. 2012 Jul;16(7):1522-32. doi: 10.1111/j.1582-4934.2011.01492.x.

25.

Human fatty acid transport protein 2a/very long chain acyl-CoA synthetase 1 (FATP2a/Acsvl1) has a preference in mediating the channeling of exogenous n-3 fatty acids into phosphatidylinositol.

Melton EM, Cerny RL, Watkins PA, DiRusso CC, Black PN.

J Biol Chem. 2011 Sep 2;286(35):30670-9. doi: 10.1074/jbc.M111.226316. Epub 2011 Jul 15.

26.

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.

Chong J, Poole P, Leung B, Black PN.

Cochrane Database Syst Rev. 2011 May 11;(5):CD002309. doi: 10.1002/14651858.CD002309.pub3. Review.

PMID:
21563134
27.

Pulmonary fibroblasts from COPD patients show an impaired response of elastin synthesis to TGF-β1.

Zhang J, Wu L, Feng MX, Sexton P, Bai CX, Qu JM, Merrilees M, Black PN.

Respir Physiol Neurobiol. 2011 Aug 15;177(3):236-40. doi: 10.1016/j.resp.2011.04.019. Epub 2011 Apr 22.

PMID:
21539942
28.

Chromosome 4q31 locus in COPD is also associated with lung cancer.

Young RP, Whittington CF, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD.

Eur Respir J. 2010 Dec;36(6):1375-82. doi: 10.1183/09031936.00033310.

29.

Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.

Wu L, Ma L, Nicholson LF, Black PN.

Respir Med. 2011 Mar;105(3):329-36. doi: 10.1016/j.rmed.2010.11.001. Epub 2010 Nov 26.

30.

Defining a relationship between dietary fatty acids and the cytochrome P450 system in a mouse model of fatty liver disease.

Gonzalez M, Sealls W, Jesch ED, Brosnan MJ, Ladunga I, Ding X, Black PN, DiRusso CC.

Physiol Genomics. 2011 Feb 11;43(3):121-35. doi: 10.1152/physiolgenomics.00209.2010. Epub 2010 Nov 23.

31.

The cyclooxygenase-2-765C promoter polymorphism protects against the development of chronic obstructive pulmonary disease.

Wu L, Merrilees M, Young RP, Black PN.

Respir Med. 2011 Mar;105(3):506-10. doi: 10.1016/j.rmed.2010.08.002. Epub 2010 Aug 17.

32.

Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study.

Morgan AR, Thompson JM, Murphy R, Black PN, Lam WJ, Ferguson LR, Mitchell EA.

BMC Med Genet. 2010 Aug 16;11:125. doi: 10.1186/1471-2350-11-125.

33.

Effect of education on the recording of medicines on admission to hospital.

Chan AH, Garratt E, Lawrence B, Turnbull N, Pratapsingh P, Black PN.

J Gen Intern Med. 2010 Jun;25(6):537-42. doi: 10.1007/s11606-010-1317-x. Epub 2010 Mar 17.

34.

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.

Poole P, Black PN.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001287. doi: 10.1002/14651858.CD001287.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD001287.

PMID:
20166060
35.

Budesonide and risk of pneumonia.

Black PN, Sexton PM.

Lancet. 2009 Dec 19;374(9707):2050-2051. doi: 10.1016/S0140-6736(09)62145-0. No abstract available.

PMID:
20109825
36.

Identification and characterization of small compound inhibitors of human FATP2.

Sandoval A, Chokshi A, Jesch ED, Black PN, Dirusso CC.

Biochem Pharmacol. 2010 Apr 1;79(7):990-9. doi: 10.1016/j.bcp.2009.11.008. Epub 2009 Nov 11. Erratum in: Biochem Pharmacol. 2012 Aug 15;84(4):580.

37.

A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers.

Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, Gardner HD, Sullivan R, Gamble GD.

Postgrad Med J. 2009 Oct;85(1008):515-24. doi: 10.1136/pgmj.2008.077107.

PMID:
19789190
38.

Methods to monitor Fatty Acid transport proceeding through vectorial acylation.

Arias-Barrau E, Dirusso CC, Black PN.

Methods Mol Biol. 2009;580:233-49. doi: 10.1007/978-1-60761-325-1_13.

PMID:
19784603
39.

Targeting the fatty acid transport proteins (FATP) to understand the mechanisms linking fatty acid transport to metabolism.

Black PN, Sandoval A, Arias-Barrau E, DiRusso CC.

Immunol Endocr Metab Agents Med Chem. 2009 Sep;9(1):11-17.

40.

Tiotropium-lessons from recent studies.

Black PN.

Respirology. 2009 Jul;14(5):623-4. doi: 10.1111/j.1440-1843.2009.01544.x. No abstract available.

PMID:
19659644
41.

Falling asleep: the determinants of sleep latency.

Nixon GM, Thompson JM, Han DY, Becroft DM, Clark PM, Robinson E, Waldie KE, Wild CJ, Black PN, Mitchell EA.

Arch Dis Child. 2009 Sep;94(9):686-9. doi: 10.1136/adc.2009.157453. Epub 2009 Jul 24.

PMID:
19633062
42.

Prevalence and determinants of cytomegalovirus infection in pre-school children.

O'Brien TP, Thompson JM, Black PN, Becroft DM, Clark PM, Robinson E, Wild C, Mitchell EA.

J Paediatr Child Health. 2009 May;45(5):291-6. doi: 10.1111/j.1440-1754.2009.01495.x.

PMID:
19493122
43.

Lung cancer susceptibility model based on age, family history and genetic variants.

Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, Gardner HD, Sullivan R, Gamble GD.

PLoS One. 2009;4(4):e5302. doi: 10.1371/journal.pone.0005302. Epub 2009 Apr 23.

44.

Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.

Black PN, McDonald CF.

Postgrad Med J. 2009 Mar;85(1001):141-7. doi: 10.1136/pgmj.2008.072439. Review.

PMID:
19351641
45.

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.

Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD.

Eur Respir J. 2009 Aug;34(2):380-6. doi: 10.1183/09031936.00144208. Epub 2009 Feb 5.

46.

Lung cancer gene associated with COPD: triple whammy or possible confounding effect?

Young RP, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD.

Eur Respir J. 2008 Nov;32(5):1158-64. doi: 10.1183/09031936.00093908.

47.

Dietary intakes of European, Māori, Pacific and Asian adults living in Auckland: the Diabetes, Heart and Health Study.

Metcalf PA, Scragg RR, Schaaf D, Dyall L, Black PN, Jackson R.

Aust N Z J Public Health. 2008 Oct;32(5):454-60. doi: 10.1111/j.1753-6405.2008.00279.x.

PMID:
18959550
48.

How often do physicians review medication charts on ward rounds?

Looi KL, Black PN.

BMC Clin Pharmacol. 2008 Sep 29;8:9. doi: 10.1186/1472-6904-8-9.

49.

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial.

Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J; Probiotic Study Group.

J Allergy Clin Immunol. 2008 Oct;122(4):788-794. doi: 10.1016/j.jaci.2008.07.011. Epub 2008 Aug 31.

PMID:
18762327
50.

Dietary polyunsaturated fatty acids (C18:2 omega6 and C18:3 omega3) do not suppress hepatic lipogenesis.

Sealls W, Gonzalez M, Brosnan MJ, Black PN, DiRusso CC.

Biochim Biophys Acta. 2008 Aug;1781(8):406-14. doi: 10.1016/j.bbalip.2008.06.010. Epub 2008 Jul 4.

PMID:
18655845

Supplemental Content

Loading ...
Support Center